From REDEFINE-1: Nausea: 55% of CagriSema participants vs 12.6% with placebo Constipation: 30.7% vs 11.6% Vomiting: 26.1% vs 4.1% Discontinuation rate: 5.9% vs 3.5% placebo comparable to Wegovy (6.9%) and Zepbound (6.2%) The nausea rate (55%) is higher than the ~4045% typical for semaglutide alone
Fasted State Recommended: For best results, avoid food intake for approximately 23 hours prior to administration
During the visit, the provider may review medical history, current medications, wellness goals, previous treatments, possible contraindications, and whether peptide therapy fits the patients overall care plan
Cut back on caffeine and processed foods, which can worsen symptoms
An engineered probiotic provides further protection by chelating cadmium and enhancing antioxidant defenses, offering a promising therapeutic strategy (128, 129)